MedTrace Logo

Open-Source Artificial Pancreas System Use Among People With Type 1 Diabetes Mellitus in China

NCT06081231 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2024-06-24

No results posted yet for this study

Summary

This real-world observational study aims to reveal the current status of the open-source artificial pancreas system (APS) use among people with T1DM in China and assess the glycemic efficacy and potential related factors of the open-source APS.

Conditions

  • Type 1 Diabetes Mellitus

Interventions

DEVICE

open-source APS;

a continuous glucose monitoring system, an insulin pump, and an intelligent algorithm.

Sponsors & Collaborators

  • Third Affiliated Hospital, Sun Yat-Sen University

    lead OTHER

Principal Investigators

  • Jinhua Yan, PHD,MD · Third Affiliated Hospital, Sun Yat-Sen University

Eligibility

Min Age
3 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2026-01-01
Completion
2026-06-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06081231 on ClinicalTrials.gov